Optimizing the Treatment of Toenail Onychomycosis Using a New Transdermal Patch Combined With Terbinafine/Ketoconazole
Phase 1
- Conditions
- Onychomycosis
- Interventions
- Drug: 3 mg terbinafine and 2 mg ketoconazole containing patchDrug: 6 mg terbinafine and 2 mg ketoconazole containing patchDrug: 8 mg terbinafine and 2 mg ketoconazole containing patch
- First Posted Date
- 2012-06-11
- Last Posted Date
- 2012-06-11
- Lead Sponsor
- Taiwan Biotech Co., Ltd.
- Target Recruit Count
- 18
- Registration Number
- NCT01615913
- Locations
- 🇨🇳
Taipei Medical University Hospital, Taipei, Taiwan
© Copyright 2025. All Rights Reserved by MedPath